2021
Omega-3 fatty acids supplementation on major cardiovascular outcomes: an umbrella review of meta-analyses of observational studies and randomized controlled trials.
Choi H, Kim J, Lee K, Kim J, Lee J, Choi E, Seong H, Kim G, Park H, Jung E, Hong S, Kronbichler A, Eisenhut M, Koyanagi A, Jacob L, Yon D, Lee S, Kim M, Kostev K, Shin J, Yang J, Smith L. Omega-3 fatty acids supplementation on major cardiovascular outcomes: an umbrella review of meta-analyses of observational studies and randomized controlled trials. European Review For Medical And Pharmacological Sciences 2021, 25: 2079-2092. PMID: 33660821, DOI: 10.26355/eurrev_202102_25113.Peer-Reviewed Original ResearchConceptsOmega-3 Fatty Acid SupplementationRandomized Controlled TrialsFatty acid supplementationClinical benefitUmbrella reviewCardiovascular outcomesMeta-analyses of observational studiesAcid supplementationCohort studyCochrane Database of Systematic ReviewsMeta-analyses of RCTsCardiovascular causesControlled TrialsDatabase of Systematic ReviewsPrevention of cardiovascular diseaseSignificant inverse associationCardiovascular diseaseEffects of omega-3 fatty acid supplementationBenefits of omega-3 supplementationLipid-lowering agentsObservational cohort studyLarge-scaled randomized controlled trialsOmega-3 supplementationInverse associationOmega-3 fatty acids
2015
Healthy Eating Index Scores are Associated with Inflammatory Markers in Breast Cancer Survivors
Arnold K, Andridge R, Logan A, Yee L, Lustberg M, Orchard T. Healthy Eating Index Scores are Associated with Inflammatory Markers in Breast Cancer Survivors. The FASEB Journal 2015, 29 DOI: 10.1096/fasebj.29.1_supplement.lb267.Peer-Reviewed Original ResearchHealthy Eating Index 2010Breast cancer survivorsTumor necrosis factor alpha receptor 2Cancer survivorsHEI scoresDiet qualityInflammatory markersIL-17IL-6Breast cancerTNFR-2Randomized placebo-controlled pilot studyOmega-3 Fatty Acid SupplementationPlacebo-controlled pilot studyEarly-stage breast cancerHealthy Eating Index scoreHealthier diet qualityStage breast cancerLower IL-6Fatty acid supplementationAromatase inhibitor treatmentAI therapyChemotherapy statusPrior chemotherapyPostmenopausal women
2011
Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis
Bloch MH, Qawasmi A. Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis. Journal Of The American Academy Of Child & Adolescent Psychiatry 2011, 50: 991-1000. PMID: 21961774, PMCID: PMC3625948, DOI: 10.1016/j.jaac.2011.06.008.Peer-Reviewed Original ResearchConceptsFatty acid supplementationAttention-deficit/hyperactivity disorderAcid supplementationOmega-3 Fatty Acid SupplementationTreatment of ADHDRandomized placebo-controlled trialBenign side effect profilePlacebo-controlled trialSide effect profilePrimary outcome measurementAnti-inflammatory propertiesTreatment of childrenCell membrane fluidityEffect of dosingAvailable pharmacotherapiesFatty acidsModest efficacyPharmacologic interventionsHyperactivity disorder symptomatologyOutcome measurementsDopamine neurotransmissionAcid doseHigh dosesPsychopharmacologic optionsMeta-analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply